Apelin, a regulator of insulin sensitivity [104], has demonstrated protective effects in diabetic retinopathy [111], while galectin-3 has been identified as a key factor in fibrosis and inflammatory responses [118], particularly in nephropathy and neuropathy [115,116,117]. This evidence concerns the gene APLN and kidney disorder.